Zobrazeno 1 - 10
of 302
pro vyhledávání: '"BRIAN F. MANDELL"'
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-10 (2018)
Abstract Background Pegloticase is a recombinant mammalian uricase conjugated to polyethylene glycol approved in the United States for treatment of chronic refractory gout. It can profoundly decrease serum urate to
Externí odkaz:
https://doaj.org/article/fede54bbd26f495c8aeb1429a4f51cb2
Autor:
Brian F. Mandell
Publikováno v:
Cleveland Clinic Journal of Medicine. 90:270-271
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e20d3bc8bab61562edcca8841b108e41
https://doi.org/10.3949/ccjm.90b.05023
https://doi.org/10.3949/ccjm.90b.05023
Autor:
Brian F. Mandell
Publikováno v:
Cleveland Clinic Journal of Medicine. 90:201-202
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e822fe1ff9932d4bfc60e67b2184990d
https://doi.org/10.3949/ccjm.90b.04023
https://doi.org/10.3949/ccjm.90b.04023
Autor:
Brian F, Mandell
Publikováno v:
Cleveland Clinic journal of medicine. 89(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d315b1bde5a92b5a46b9ca2c6a5c5399
https://pubmed.ncbi.nlm.nih.gov/36455970
https://pubmed.ncbi.nlm.nih.gov/36455970
Autor:
Brian F, Mandell
Publikováno v:
Cleveland Clinic journal of medicine. 89(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9a365c730d4e4ab04ab5ce59623d7606
https://pubmed.ncbi.nlm.nih.gov/36319051
https://pubmed.ncbi.nlm.nih.gov/36319051
Autor:
Brian F. Mandell
Publikováno v:
Cleveland Clinic journal of medicine. 89(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::897647562b1295a4be3f40d6eb0ae84f
https://pubmed.ncbi.nlm.nih.gov/36192025
https://pubmed.ncbi.nlm.nih.gov/36192025
Publikováno v:
Clinical and Experimental Rheumatology. 39:1085-1092
To determine factors associated with gout flares in subjects treated with pegloticase.Gout flares from two randomised controlled trials comparing pegloticase (8 mg every 2 weeks [q2] or monthly [q4]) versus placebo were analysed. Responders had persi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d1a804ef4db5296ec85a183a0b8f174
https://doi.org/10.55563/clinexprheumatol/b7jjnb
https://doi.org/10.55563/clinexprheumatol/b7jjnb
Autor:
Brian F. Mandell
Publikováno v:
Cleveland Clinic Journal of Medicine. 90:135-136
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0744bd963dc4eb288dd224e7caa7bdac
https://doi.org/10.3949/ccjm.90b.03023
https://doi.org/10.3949/ccjm.90b.03023
Autor:
Brian F. Mandell
Publikováno v:
Cleveland Clinic Journal of Medicine. 90:72-73
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57d9c2dd283011448b4e1402cbb294df
https://doi.org/10.3949/ccjm.90b.02023
https://doi.org/10.3949/ccjm.90b.02023
Autor:
Brian F. Mandell
Publikováno v:
Cleveland Clinic Journal of Medicine. 90:13-14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ace14a546e133be88dee256c9483969b
https://doi.org/10.3949/ccjm.90b.01023
https://doi.org/10.3949/ccjm.90b.01023